Intellectual Property India Publishes Patent Application for 'Antibody Or Antigen-Binding Fragment Thereof' Filed by Karydo Therapeutix, Inc.

MUMBAI, India, Sept. 26 -- Intellectual Property India has published a patent application (202517085446 A) filed by Karydo Therapeutix, Inc., Tokyo, on Sept. 9, for 'antibody or antigen-binding fragment thereof.'

Inventor(s) include Sato, Narutoku.

The application for the patent was published on Sept. 26, under issue no. 39/2025.

According to the abstract released by the Intellectual Property India: "The present invention addresses the problem of providing an antibody capable of detecting human PRB1 protein in serum as well as saliva. The problem is solved by an antibody capable of binding to human PRB1 protein or an antigen-binding fragment of the antibody. The antibody has a configuration such that a heavy-chain variable region comprises an amino acid sequence having 95% or higher identity to a heavy-chain variable region represented by an amino acid sequence lying between position-21 to position-141 in SEQ ID NO:11, and a light-chain variable region comprises an amino acid sequence having 95% or higher identity to a light-chain variable region represented by an amino acid sequence lying between position-26 to position-132 in SEQ ID NO:16."

The patent application was internationally filed on Mar. 01, 2024, under International application No.PCT/JP2024/007914.

Disclaimer: Curated by HT Syndication.